Polyunsaturated fatty acids changes during electroconvulsive therapy in major depressive disorder

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Background:

• Polyunsaturated fatty acids (PUFAs) play a role in brain function and major depressive disorder (MDD) pathophysiology.
• The relationship between PUFAs and electroconvulsive therapy (ECT) efficacy in MDD remains unexplored.

Purpose of the Study:

• To investigate the association between PUFA concentrations and ECT response in patients diagnosed with MDD.
• To identify specific PUFAs that may predict treatment outcomes in MDD patients undergoing ECT.

Main Methods:

• A multicenter study involving 45 patients with unipolar MDD undergoing ECT.
• Blood samples were collected to measure PUFA concentrations at baseline (T0) and during treatment (T12).
• Depression severity was assessed using the Hamilton Rating Scale for Depression (HAM-D); response was categorized as early, late, or no response.

Main Results:

• A higher PUFA chain length index (CLI) was observed in late responders compared to non-responders.
• Significantly higher concentrations of nervonic acid (NA) were found in late responders versus early and non-responders.
• Individual PUFAs and indices like CLI and unsaturation index (UI) showed associations with ECT response.

Conclusions:

• This study provides initial evidence linking PUFA levels to ECT efficacy in MDD.
• PUFAs may influence ECT outcomes through their effects on neuronal electrochemistry and neurogenesis.
• PUFAs represent a potentially modifiable factor for predicting and possibly enhancing ECT treatment success.